Get started
Author

Antonin Serrano

Synergistic action of the MCL-1 inhibitor S63845 with current therapies in preclinical models of triple-negative and HER2-amplified breast cancer
2017 · Delphine Merino, James R. Whittle, et al. · Science Translational Medicine · 195
Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer
2019 · D. Merino, T. S. Weber, et al. · Nature Communications · 142
PDF
Mastering the use of cellular barcoding to explore cancer heterogeneity
2022 · Antonin Serrano, Jean Berthelet, et al. · Nature reviews. Cancer · 53
The site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile
2021 · Jean Berthelet, Verena C. Wimmer, et al. · Science Advances · 44
Experimental and spontaneous metastasis assays can result in divergence in clonal architecture
2023 · Antonin Serrano, Tom Weber, et al. · Communications Biology · 21
PDF
Genetic barcoding uncovers the clonal makeup of solid and liquid biopsies and their ability to capture intra-tumoral heterogeneity
2026 · Antonin Serrano, Tom S Weber, et al. · Molecular Systems Biology · 2
Computational Screening of Anti-Cancer Drugs Identifies a New BRCA Independent Gene Expression Signature to Predict Breast Cancer Sensitivity to Cisplatin
2022 · Jean Berthelet, Momeneh Foroutan, et al. · Cancers · 2
PDF
Publisher Correction: Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer
2019 · D. Merino, T. S. Weber, et al. · Nature Communications · 2
PDF
The site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile
2021 · Jean Berthelet, VC Wimmer, et al. · La Trobe University
Works count: 10
Citation count: 461
H-index: 5
I10-index: 5
Year
Topic
Type